Gene · 55902
Papers1,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Redox mechanism of glycerophospholipids and relevant targeted therapy in ferroptosis. | Cell Death Discov | 2025 | 40744916 | PubTator, text mining | PubMed |
| Comprehensive landscape of cell death mechanisms: from molecular cross-talk to therapeutic innovation in oncology. | Front Cell Dev Biol | 2025 | 40741332 | PubTator, text mining | PubMed |
| Epigenetic modifications of gut microbiota and their potential role in atherosclerosis. | Front Pharmacol | 2025 | 40740992 | PubTator, text mining | PubMed |
| ACSS2 in pan-cancer context: multi-omics insights into metabolic reprogramming and immunotherapy response. | Comput Biol Med | 2025 | 40729863 | PubTator, text mining | PubMed |
| Epigenetic Control of Cardiomyocyte Necrosis: Targeting ACSS2 to Attenuate Myocardial Ischemia/Reperfusion Injury. | J Cardiovasc Transl Res | 2025 | 40721980 | PubTator, text mining | PubMed |
| Response to Editorial Note: "Epigenetic Control of Cardiomyocyte Necrosis: Targeting ACSS2 to Attenuate Myocardial Ischemia/Reperfusion Injury". | J Cardiovasc Transl Res | 2025 | 40711503 | PubTator, text mining | PubMed |
| High fructose promotes MYCN-amplified neuroblastoma progression through NgBR-ACSS2-mediated biosynthesis of acetyl-CoA. | Cell Rep | 2025 | 40616844 | PubTator, text mining | PubMed |
| Acetyl-CoA Short-Chain Synthetase-2 Regulates Myocardial Ischemia/Reperfusion Injury by Targeting Histone Acetylation. | J Cardiovasc Transl Res | 2025 | 40593298 | PubTator, text mining | PubMed |
| MAPK Signaling in the Interplay Between Oxidative Stress and Autophagy. | Antioxidants (Basel) | 2025 | 40563296 | PubTator, text mining | PubMed |
| Histone and non-histone lactylation: molecular mechanisms, biological functions, diseases, and therapeutic targets. | Mol Biomed | 2025 | 40484921 | PubTator, text mining | PubMed |
| The mechanism of acetyl-CoA synthase through the lens of a nickel model system. | Nat Commun | 2025 | 40467565 | PubTator, text mining | PubMed |
| The advances in acetylation modification in senescence and aging-related diseases. | Front Physiol | 2025 | 40421455 | PubTator, text mining | PubMed |
| Histone modifications and metabolic reprogramming in tumor-associated macrophages: a potential target of tumor immunotherapy. | Front Immunol | 2025 | 40375990 | PubTator, text mining | PubMed |
| TIGIT deficiency promotes autoreactive CD4+ T-cell responses through a metabolic‒epigenetic mechanism in autoimmune myositis. | Nat Commun | 2025 | 40374622 | PubTator, text mining | PubMed |
| Macrophage-augmented intestinal organoids model virus-host interactions in enteric viral diseases and facilitate therapeutic development. | Nat Commun | 2025 | 40368896 | PubTator, text mining | PubMed |
| SIRT2-mediated ACSS2 K271 deacetylation suppresses lipogenesis under nutrient stress. | Elife | 2025 | 40331334 | PubTator, text mining | PubMed |
| A Computational Approach for Designing a Peptide-Based Acetyl-CoA Synthetase 2 Inhibitor: A New Horizon for Anticancer Development. | Cell Biochem Biophys | 2025 | 40287570 | PubTator, text mining | PubMed |
| Assessment of Soil Health Through Metagenomic Analysis of Bacterial Diversity in Russian Black Soil. | Microorganisms | 2025 | 40284690 | PubTator, text mining | PubMed |
| The Missing Enzymes: A Call to Update Pharmacological Profiling Practices for Better Drug Safety Assessment. | J Med Chem | 2025 | 40173276 | PubTator, text mining | PubMed |
| E-FTMap: A Protein Structure Based Pharmacophore Identification Server for Guiding Fragment Expansion. | J Mol Biol | 2025 | 40133782 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55902/papers?page=7